Jpmorgan Chase & CO I Teos Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 467,319 shares of ITOS stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

467,319

Previous 461,951 1.16%

Holding current value

$3.37 Million

Previous $6.86 Million 30.4%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$10.09 - $17.97 $54,163 - $96,462	5,368 Added 1.16%	467,319 $4.77 Million
Q2 2024 Aug 12, 2024	BUY	$10.33 - $18.09 $4.59 Million - $8.04 Million	444,193 Added 2501.37%	461,951 $6.86 Million
Q1 2024 May 10, 2024	SELL	$9.89 - $13.64 $54,335 - $74,938	-5,494 Reduced 23.63%	17,758 $242,000
Q4 2023 Feb 12, 2024	SELL	$8.57 - $11.06 $3,847 - $4,965	-449 Reduced 1.89%	23,252 $254,000
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $35,620 - $47,493	3,253 Added 15.91%	23,701 $259,000
Q2 2023 Aug 11, 2023	SELL	$12.93 - $18.05 $6.54 Million - $9.13 Million	-505,709 Reduced 96.11%	20,448 $270,000
Q1 2023 May 18, 2023	BUY	$13.02 - $22.62 $391,198 - $679,640	30,046 Added 6.06%	526,157 $7.16 Million
Q1 2023 May 11, 2023	SELL	$13.02 - $22.62 $1.14 Million - $1.99 Million	-87,847 Reduced 15.04%	496,111 $6.75 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $729,511 - $886,744	41,053 Added 7.56%	583,958 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$18.6 - $27.25 $304,928 - $446,736	-16,394 Reduced 2.93%	542,905 $10.3 Million
Q2 2022 Aug 11, 2022	BUY	$16.57 - $35.1 $5.51 Million - $11.7 Million	332,625 Added 146.74%	559,299 $11.5 Million
Q1 2022 May 11, 2022	BUY	$31.92 - $47.45 $5.36 Million - $7.97 Million	167,992 Added 286.28%	226,674 $7.3 Million
Q4 2021 Feb 10, 2022	BUY	$26.23 - $47.86 $1.16 Million - $2.11 Million	44,131 Added 303.28%	58,682 $2.73 Million
Q3 2021 Nov 12, 2021	BUY	$23.91 - $29.58 $347,914 - $430,418	14,551 New	14,551 $393,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO I Teos Therapeutics, Inc. Transaction History